10x Genomics stock slides premarket after insider sales filing as traders eye next catalyst
New York, Feb 27, 2026, 09:24 EST — Premarket 10x Genomics shares dropped roughly 3.3% to $21.40 ahead of Friday’s open, giving back some ground after a late-session dip that followed a big rally the session before. Thursday’s close landed at $22.13, a 12.6% gain.